News

Filter

Current filters:

None

1 to 9 of 97902 results

InMed appoints Abo Mohammed as chief medical officer

InMed appoints Abo Mohammed as chief medical officer

04-03-2015

Canadian cannabinoid therapy specialist InMed Pharmaceuticals has appointed Abo Mohammed as chief medical…

BoardroomCanadaInMedInMed PharmaceuticalsPharmaceutical

FDA accepts Bayer's BLA for hemophilia A agent Kovaltry

FDA accepts Bayer's BLA for hemophilia A agent Kovaltry

04-03-2015

The US Food and Drug Administration has accepted German pharma major Bayer’s Biologics License Application…

BAY 81-8973BayerBiotechnologyHematologyKovaltryRegulationUSA

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

04-03-2015

Clinical-stage biopharma company arGEN-X has exercised its option to exclusively license preclinical…

arGEN-XBelgiumBiotechnologyLicensingOncology

Ipsen appoints Dominique Laymand as senior vice president, chief ethics and compliance officer

Ipsen appoints Dominique Laymand as senior vice president, chief ethics and compliance officer

04-03-2015

French drug maker Ipsen has appointed Dominique Laymand as senior vice president, chief ethics and compliance…

BoardroomDominique LaymandFranceIpsenIpsen Group

Pharma CEO salaries and performance pay “is not politicians’ business,” says Polyplus chief

Pharma CEO salaries and performance pay “is not politicians’ business,” says Polyplus chief

04-03-2015

The political establishment needs to concentrate on cleaning up its own act and concentrating on their…

ManagementPharmaceuticalPoliticsPolyplusSanofi

US FDA warns on over-prescribing of testosterone products

US FDA warns on over-prescribing of testosterone products

04-03-2015

The US Food and Drug Administration is requiring that the manufacturers of all approved prescription…

AbbVieAndroGelAxironEli LillyMen's HealthPharmaceuticalRegulationUSA

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

04-03-2015

Analysts at Morningstar Equity Research see significantly more opportunity than the overall market for…

AstraZenecaBiotechnologyBristol-Myers SquibbMarkets & MarketingMerck & CoOncologyOpdivoResearchRoche

CASI Pharmaceuticals appoints Rong Chen as chief medical officer

CASI Pharmaceuticals appoints Rong Chen as chief medical officer

04-03-2015

Oncology biopharma company CASI Pharmaceuticals has appointed Rong Chen as chief medical officer.

BoardroomCASICASI PharmaceuticalsGlaxoSmithKlinePharmaceutical

1 to 9 of 97902 results

COMPANY SPOTLIGHT

Menarini

Back to top